PCI Biotech Holding ASA Statistics
Total Valuation
PCI Biotech Holding ASA has a market cap or net worth of NOK 69.05 million. The enterprise value is 38.99 million.
Market Cap | 69.05M |
Enterprise Value | 38.99M |
Important Dates
The last earnings date was Wednesday, August 28, 2024.
Earnings Date | Aug 28, 2024 |
Ex-Dividend Date | n/a |
Share Statistics
PCI Biotech Holding ASA has 37.33 million shares outstanding.
Shares Outstanding | 37.33M |
Shares Change (YoY) | n/a |
Shares Change (QoQ) | n/a |
Owned by Insiders (%) | 4.76% |
Owned by Institutions (%) | 13.82% |
Float | 30.74M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
PB Ratio | n/a |
P/FCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | -2.45 |
EV / Sales | 6.50 |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 6.86, with a Debt / Equity ratio of 1.49.
Current Ratio | 6.86 |
Quick Ratio | 6.86 |
Debt / Equity | 1.49 |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | -174.46 |
Financial Efficiency
Return on equity (ROE) is -40.38% and return on invested capital (ROIC) is -27.85%.
Return on Equity (ROE) | -40.38% |
Return on Assets (ROA) | -24.73% |
Return on Capital (ROIC) | -27.85% |
Revenue Per Employee | 999,833 |
Profits Per Employee | -2.65M |
Employee Count | 6 |
Asset Turnover | 0.13 |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -4.15% in the last 52 weeks. The beta is 1.71, so PCI Biotech Holding ASA's price volatility has been higher than the market average.
Beta (5Y) | 1.71 |
52-Week Price Change | -4.15% |
50-Day Moving Average | 1.79 |
200-Day Moving Average | 1.92 |
Relative Strength Index (RSI) | 56.68 |
Average Volume (20 Days) | 93,691 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, PCI Biotech Holding ASA had revenue of NOK 6.00 million and -15.91 million in losses.
Revenue | 6.00M |
Gross Profit | 6.00M |
Operating Income | -17.80M |
Pretax Income | -15.91M |
Net Income | -15.91M |
EBITDA | -17.81M |
EBIT | -17.80M |
Earnings Per Share (EPS) | n/a |
Balance Sheet
The company has 30.54 million in cash and 475,000 in debt, giving a net cash position of 30.06 million or 0.81 per share.
Cash & Cash Equivalents | 30.54M |
Total Debt | 475,000 |
Net Cash | 30.06M |
Net Cash Per Share | 0.81 |
Equity (Book Value) | 31.91M |
Book Value Per Share | n/a |
Working Capital | 31.56M |
Cash Flow
Operating Cash Flow | -14.59M |
Capital Expenditures | n/a |
Free Cash Flow | n/a |
FCF Per Share | n/a |
Margins
Gross margin is 100.00%, with operating and profit margins of -296.63% and -265.24%.
Gross Margin | 100.00% |
Operating Margin | -296.63% |
Pretax Margin | -265.24% |
Profit Margin | -265.24% |
EBITDA Margin | -296.92% |
EBIT Margin | -296.63% |
FCF Margin | n/a |
Dividends & Yields
PCI Biotech Holding ASA does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | n/a |
Shareholder Yield | n/a |
Earnings Yield | n/a |
FCF Yield | n/a |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |